Momenta Pharmaceuticals Cash Flow

Health Care & Life Sciences » Biotechnology | Momenta Pharmaceuticals Inc.

Momenta Pharmaceuticals Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.

2013

2014

2015

2016

2017

2018

Net Income before Extraordinaries

108,408.00

98,600.00

83,313.00

21,003.00

88,096.00

176,061

Depreciation, Depletion & Amortization

8,169.00

8,698.00

8,655.00

9,122.00

9,176.00

11,070

Other Funds

16,664.00

15,756.00

12,823.00

18,917.00

16,355.00

24,902

Funds from Operations

83,575.00

74,146.00

61,835.00

7,036.00

62,565.00

140,089

Changes in Working Capital

3,257.00

8,978.00

9,739.00

852.00

32,209.00

15,501

Net Operating Cash Flow

86,832.00

65,168.00

71,574.00

7,888.00

30,356.00

155,590

Capital Expenditures

9,450.00

8,360.00

4,068.00

5,609.00

17,127.00

Purchase/Sale of Investments

68,036.00

83,533.00

159,766.00

85,657.00

104,219.00

Net Investing Cash Flow

58,586.00

75,173.00

163,834.00

80,048.00

121,079.00

Net Financing Cash Flow

5,022.00

21,578.00

235,461.00

1,341.00

74,348.00

Net Change in Cash

23,224.00

31,583.00

53.00

89,277.00

77,087.00

Free Cash Flow

96,282.00

73,528.00

75,642.00

2,279.00

47,483.00

Other Sources

267.00

Change in Capital Stock